Advertisement

Hernia

, Volume 10, Issue 6, pp 498–501 | Cite as

Collagen in colon disease

  • Michael Stumpf
  • Carsten Johannes Krones
  • Uwe Klinge
  • Rafael Rosch
  • Karsten Junge
  • Volker Schumpelick
Review
First Online:

Abstract

The pathophysiology of wound healing in the bowel wall suggests that collagen and matrix metalloproteinases (MMPs) have an important role in the changes of the bowel wall seen in several colonic diseases. Several recent studies suggest that disturbances of the collagen texture and the extracellular matrix (ECM) metabolism are major factors leading to the onset of diverticular disease. Changes of the ECM also play a role in the development of inflammatory bowel diseases. Regarding the permanent remodeling of the bowel wall, any imbalance of the ECM could support the onset of chronic inflammation and the development of fistula formation, such as that seen in patients with Crohn’s disease. Disturbances of the ECM play a role in the pathogenesis of anastomotic leakage after large bowel surgery and suggest the presence of a genetically defined risk population with disturbed wound healing mechanisms. This concept could explain the well known situation where an anastomotic breakdown is observed, despite the absence of other known risk factors and after a technically correct anastomosis.

Keywords

Extracellular matrix Bowel disease MMPs Anastomotic leakage Diverticular diseases Crohn’s disease 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Fleischmajer R, Perlish JS, Burgeson RE, Shaikh-Bahai F, Timpl R (1990) Type I and type III collagen interactions during fibrillogenesis. Ann N Y Acad Sci 580(1):161–175PubMedCrossRefGoogle Scholar
  2. 2.
    Sommerville RP, Oblander SA, Apte SS (2003) Matrix metalloproteinases: old dogs with new tricks. Genome Biol 4(6):216–222CrossRefGoogle Scholar
  3. 3.
    Painter NS, Truelove SC, Ardran GM, Tuckey M (1965) Segmentation and the localization of intraluminal pressures in the human colon, with special reference to the pathogenesis of colonic diverticula. Gastroenterology 49:169–177PubMedGoogle Scholar
  4. 4.
    Schoetz DJ Jr (1999) Diverticular disease of the colon: a century-old problem. Dis Colon Rectum 42(6):703–709PubMedCrossRefGoogle Scholar
  5. 5.
    Whiteway J, Morson BC (1985) Elastosis in diverticular disease of the sigmoid colon. Gut 26(3):258–266PubMedGoogle Scholar
  6. 6.
    Watters DAK, Smith AN, Eastwood MA, Anderson KC, Elton RA, Mugerwa JW (1985) Mechanical properties of the colon: comparison of the features of the African and European colon in vitro. Gut 26(4):384–392PubMedGoogle Scholar
  7. 7.
    Wess L, Eastwood MA, Wess TJ, Busuttil A, Miller A (1995) Cross linking of collagen is increased in colonic diverticulosis. Gut 37(1):91–94PubMedGoogle Scholar
  8. 8.
    Hoffmann P, Layer P (1995) Pathogenesis and pathophysiology of sigmoid diverticulitis (in German). Chirurg 66(12):1169–1172PubMedGoogle Scholar
  9. 9.
    Stumpf M, Cao W, Klinge U, Klosterhalfen B, Kasperk R, Schumpelick V (2001) Increased distribution of collagen type III and reduced expression of matrix metalloproteinase 1 in patients with diverticular disease. Int J Colorectal Dis 16(5):271–275PubMedCrossRefGoogle Scholar
  10. 10.
    Parra-Blanco A (2006) Colonic diverticular disease: pathophysiology and clinical picture. Digestion 73(Suppl 1):47–57PubMedCrossRefGoogle Scholar
  11. 11.
    Okabe N (2001) The pathogenesis of Crohn’s disease. Digestion 63(Suppl 1):52–59PubMedCrossRefGoogle Scholar
  12. 12.
    Brignola C, Belloli C, Ardizzone S, Astegiano M, Cottone M, Trallori G (2000) The relationship between heritability and smoking habits in Crohn’s disease. Italian Cooperative Study Group. Am J Gastroenterol 95(11):3171–3175PubMedCrossRefGoogle Scholar
  13. 13.
    Jorgensen LN, Kallehave F, Christensen E, Siana JE, Gottrup F (1998) Less collagen production in smokers. Br J Surg 123(4):450–455Google Scholar
  14. 14.
    Alexander AC, Irving MH (1990) Accumulation and pepsin solubility of collagens in the bowel of patients with Crohn’s disease. Dis Colon Rectum 33(11):956–962PubMedCrossRefGoogle Scholar
  15. 15.
    Stallmach A, Schuppan D, Riese HH, Metthes H, Riecken EO (1992) Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn’s disease. Gastroenterology 102(6):1920–1929PubMedGoogle Scholar
  16. 16.
    Stumpf M, Cao W, Klinge U, Klosterhalfen B, Junge K, Krones CJ, Schumpelick V (2005) Reduced expression of collagen type I and increased expression of matrix metalloproteinases 1 in patients with Crohn’s Disease. J Invest Surg 18(1):33–38PubMedCrossRefGoogle Scholar
  17. 17.
    Kjeldsen J, Schaffalitzky de Muckadell OB, Junker P (1995) Seromarkers of collagen I and III metabolism in active Crohn’s disease. Relation to disease activity and response to therapy. Gut 37(6):805–810PubMedGoogle Scholar
  18. 18.
    Louis E, Ribbens C, Godon A, Franchimont D, De Groote D, Hardy N, Boniver J, Belaiche J, Malaise M (2000) Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol 120(2):241–246PubMedCrossRefGoogle Scholar
  19. 19.
    von Lampe B, Barthel B, Coupland SE, Riecken EO, Rosewicz S (2000) Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47(1):63–73CrossRefGoogle Scholar
  20. 20.
    McKaig BC, McWilliams D, Watson SA, Mahida YR (2003) Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease. Am J Pathol 162(4):1355–1360PubMedGoogle Scholar
  21. 21.
    Matthiessen P, Hallbook O, Rutegard J, Sjjodahl R (2006) Population-based study of risk factors for postoperative death after anterior resection of the rectum. Br J Surg 93(4):498–503PubMedCrossRefGoogle Scholar
  22. 22.
    Alves A, Panis Y, Trancart D, Regimbeau JM, Pocard M, Valleur P (2002) Factors associated with clinically significant anastomotic leakage after large bowel resection: multivariate analysis of 707 patients. World J Surg 26(4):499–502PubMedCrossRefGoogle Scholar
  23. 23.
    Stumpf M, Klinge U, Wilms A, Zabrocki R, Rosch R, Junge K, Krones CJ, Schumpelick V (2005) Changes of the extracellular matrix as a risk factor for anastomotic leakage after large bowel surgery. Surgery 137(2):229–234PubMedCrossRefGoogle Scholar
  24. 24.
    Baker EA, Leaper DJ (2003) The plasminogen activator and matrix metalloproteinase system in colorectal cancer: relationship to tumor pathology. Eur J Cancer 39:981–988PubMedCrossRefGoogle Scholar
  25. 25.
    Di Cholandrea T, Wang L, Wille J, D’Armiento J, Chada KK (1998) Epidermal expression of collagenase delays wound-healing in transgenic mice. J Invest Dermatol 111(6):1029–1033CrossRefGoogle Scholar
  26. 26.
    Stumpf M, Cao W, Klinge U, Klosterhalfen B, Kasperk R, Schumpelick V (2002) Collagen distribution and expression of matrix metalloproteinases 1 and 13 in patients with anastomotic leakage after large-bowel surgery. Langenbecks Arch Surg 386(7):502–506PubMedCrossRefGoogle Scholar
  27. 27.
    Stumpf M, Klinge U, Mertens PR (2004) Anastomotic leakage in the gastrointestinal tract-repair and prognosis (in German). Chirurg 75(11):1056–1062PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Michael Stumpf
    • 1
  • Carsten Johannes Krones
    • 1
  • Uwe Klinge
    • 1
  • Rafael Rosch
    • 1
  • Karsten Junge
    • 1
  • Volker Schumpelick
    • 1
  1. 1.Department of Surgery, Medical Faculty, University HospitalRhenish-Westphalian Technical University (RWTH)AachenGermany

Personalised recommendations